David R. Healy

A Novel, Non-Prostanoid EP2 Receptor-Selective Prostaglandin E2 Agonist Stimulates Local Bone Formation and Enhances Fracture Healing

Mei Li, Hua Zhu Ke, Hong Qi et al. · Journal of Bone and Mineral Research · 2003 · 116 citations

Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice

M. Li, David R. Healy, Y. Li et al. · Bone · 2005 · 84 citations

Mechanobiology, Impaired Fracture, Bone Remodeling +9

Circulating Bone Morphogenetic Protein 1–3 Isoform Increases Renal Fibrosis

Lovorka Grgurević, Boris Maček, David R. Healy et al. · Journal of the American Society of Nephrology · 2011 · 60 citations · Full text

Surface-specific effects of a PPARγ agonist, darglitazone, on bone in mice

M. Li, Lydia C. Pan, Hollis A. Simmons et al. · Bone · 2006 · 55 citations

Molecular Pharmacology, Pparγ Agonist, Molecular Physiology +10

Short term immobilization-induced cancellous bone loss is limited to regions undergoing high turnover and/or modeling in mature rats

V. Shen, X.G. Liang, R. Birchman et al. · Bone · 1997 · 48 citations · Full text

Bone Resorption, Gynecology, Orthopaedic Surgery +17